Seeking AlphaCRISPR Therapeutics: Elucidating The New CRISPR/Cas9 Exploratory FindingsSeeking AlphaOn Jan 09, 2018, the share price of CRISPR Therapeutics (NASDAQ:CRSP), a gene-editing and CAR-T-focused firm to service serious conditions like cancers a… Continue reading
Deccan ChronicleNew treatment for cancer: Immunotherapy with dendritic cells, now in IndiaDeccan ChronicleIn India LDG India has initiated this medical facility in collaboration with the renowned Germany based laboratory “Dr. Gansuage”. “We are proud o… Continue reading
Medical XpressRare melanoma type highly responsive to immunotherapyMedical Xpress"Our findings challenge the previous school of thought that immunotherapy would offer little benefit to patients with desmoplastic melanoma due to the dense tissue ar… Continue reading
News-Medical.net |
Company-sponsored CRISPR clinical studies to begin in 2018
News-Medical.net This year could be a defining one for CRISPR, the gene editing technique, which has been hailed as an important breakthrough in laboratory research. That’s because the first company-sponsored clinical studies will be conducted to see if it can help … |
ActionNewsJax.com |
Mayo Clinic cleared to create larger batches of stem cells for clinical trials
ActionNewsJax.com Bu showed Action News Jax stem cells that were reprogrammed genetically and showed those neurons firing, which resembles what you’d see in the human brain. Stem cell production has long been a labor-intensive process in which researchers cultivate … |
ActionNewsJax.com |
Mayo Clinic cleared to create larger batches of stem cells for clinical trials
ActionNewsJax.com Bu showed Action News Jax stem cells that were reprogrammed genetically and showed those neurons firing, which resembles what you’d see in the human brain. Stem cell production has long been a labor-intensive process in which researchers cultivate … |
Fox News |
A newly approved gene therapy cures blindness — but it costs nearly $1M
Fox News Christian was eventually able to see again, thanks to a breakthrough drug recently approved by the Food and Drug Administration. The FDA’s approval of Luxturna, the first gene therapy to treat a specific inherited gene mutation, RPE65 – has been deemed … |
Winnipeg Free Press |
Family of nurse with rare disease searching for stem cell donors
Winnipeg Free Press Sheila Wolfe is a nurse with leukemia who’s in desperate need of a stem cell transplant. Her family is organizing a stem cell registry drive at Victoria Hospital Thursday. A Winnipeg nurse who has saved lives for the last 25 years now needs the public … |